118 related articles for article (PubMed ID: 1271892)
1. Modified tumor cells in the immunotherapy of solid mammary tumors.
Simmons RL; Rios A; Trites P
Med Clin North Am; 1976 May; 60(3):551-65. PubMed ID: 1271892
[No Abstract] [Full Text] [Related]
2. Neuraminidase treated cells and their role in cancer immunotherapy.
Simmons RL; Rios A
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
[No Abstract] [Full Text] [Related]
3. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
Rios A; Simmons RL
Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
[No Abstract] [Full Text] [Related]
4. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
Simmons RL; Rios A
Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
[No Abstract] [Full Text] [Related]
5. Experimental cancer immunotherapy: modification of tumor cells to increase immunogenicity.
Rios A; Simmons RL
Ann N Y Acad Sci; 1976; 276():45-60. PubMed ID: 68699
[TBL] [Abstract][Full Text] [Related]
6. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
Simmons RL; Rios A
Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
[No Abstract] [Full Text] [Related]
7. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
Simmons RL; Rios A
Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
[No Abstract] [Full Text] [Related]
8. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
Simmons RL; Rios A
J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
[No Abstract] [Full Text] [Related]
9. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
Rios A; Simmons RL
Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
[No Abstract] [Full Text] [Related]
10. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
Simmons RL; Rios A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
[No Abstract] [Full Text] [Related]
11. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
Iorio AM; Rivosecchi P; Santoni A; Fabiani L
Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
[No Abstract] [Full Text] [Related]
12. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
Spence RJ; Simon RM; Baker AR
J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
[TBL] [Abstract][Full Text] [Related]
13. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
[No Abstract] [Full Text] [Related]
14. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
15. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
Simmons RL; Rios A
Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
[No Abstract] [Full Text] [Related]
16. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
Song CW; Levitt SH
Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
[No Abstract] [Full Text] [Related]
17. Neuraminidase immunotherapy of tumors in man.
Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
[No Abstract] [Full Text] [Related]
18. Therapy in an intracerebral murine glioma model, using Bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Albright L; Madigan JC; Gaston MR; Houchens DP
Cancer Res; 1975 Mar; 35(3):658-65. PubMed ID: 234790
[TBL] [Abstract][Full Text] [Related]
19. Effect of immunotherapy, chemotherapy, and surgery on tumor immunity in mice.
Tanaka T; Sasaki N
Gan; 1974 Oct; 65(5):395-402. PubMed ID: 4435340
[No Abstract] [Full Text] [Related]
20. Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer.
Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
Int J Cancer; 1974 Mar; 13(3):389-403. PubMed ID: 4822108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
